Ads
related to: drugs, lung cancer- Patient & Caregiver Info
Download Patient Brochures & Get
Additional Support For Caregivers
- Dosing Information
Review Dosing & Administration
Recommendations For Your Patients
- Resources For Physicians
View & Download Important Resources
Testing Info, Access Kits & More
- Learn About KRAS G12C
Find Testing Info & Get Resources
For HCPs, Patients & Caregivers
- Review Safety Information
Learn More About Important Safety
Info On The Official Physician Site
- Connect With A Rep
HCPs & Physicians Register Today To
Be Connected With A Representative
- Patient & Caregiver Info
Search results
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 3 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Lung cancer wonder drug hailed as study shows 'off the chart' survival benefit
Daily Express· 5 days agoResults from a trial of daily pill lorlatinib were described as "unprecedented".
Pfizer says its its lung cancer drug Lorbrena could be a $1 billion blockbuster
Quartz· 5 days agoPharma giant Pfizer said that its lung cancer drug Lorbrena could reach blockbuster status by 2030...
Strong trial results for Pfizer lung cancer drug
Medical Xpress· 5 days agoRoughly half received lorlatinib while the rest received crizotinib, an earlier generation drug. After five years of follow-up time, more than half of...
Pfizer drug extends life for people with rare form of lung cancer | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 5 days agoA Pfizer lung cancer drug has been shown to greatly reduce tumor progression and improve survival...
Incurable lung cancer could be ‘stopped in its tracks’ by new pill
The Telegraph via Yahoo News· 5 days agoPatients with an incurable form of lung cancer could lead normal lives by taking a daily pill that...
Summit Shares Soar After Lung Cancer Drug Tops Keytruda in Study
Bloomberg· 6 days agoSummit Therapeutics Inc. shares jumped after the biotech company said a late-stage trial met its...
Phase III trial shows lorlatinib highly effective against ALK-positive non–small cell lung cancer
Medical Xpress· 17 hours agoA large team of medical researchers and doctors has found via phase III clinical trial that the ALK inhibitor lorlatinib is highly effective for treating non–small cell lung
Bristol’s $250,000 pill slows lung cancer growth by 7 weeks
San Francisco Chronicle· 2 days agoA Bristol Myers Squibb Co. lung cancer treatment delayed tumor growth by less than seven weeks in a closely watched clinical trial, a disappointing result ...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 5 days agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
Ads
related to: drugs, lung cancer